{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:55:13Z","timestamp":1793170513103,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the significant progress made in South Africa in getting millions of individuals living with HIV into care, many patients still present or re-enter care with Advanced HIV Disease (AHD). We aimed to estimate the prevalence of AHD among ART-naive and ART-experienced patients in South Africa using studies published between January 2010 and May 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched for relevant data on PubMed, CINAHL, Scopus and other sources, with a geographical filters limited to South Africa, up to May 31, 2022. Two reviewers conducted all screening, eligibility assessment, data extraction, and critical appraisal. We synthesized the data using the inverse-variance heterogeneity model and Freeman-Tukey transformation. We assessed heterogeneity using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic and publication bias using the Egger and Begg\u2019s test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 2,496 records, of which 53 met the eligibility criteria, involving 11,545,460 individuals. The pooled prevalence of AHD among ART-naive and ART-experienced patients was 43.45% (95% CI 40.1\u201346.8%, n\u2009=\u200953 studies) and 58.6% (95% CI 55.7 to 61.5%, n\u2009=\u20092) respectively. The time trend analysis showed a decline of 2% in the prevalence of AHD among ART-naive patients per year. However, given the high heterogeneity between studies, the pooled prevalence should be interpreted with caution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite HIV\u2019s evolution to a chronic disease, our findings show that the burden of AHD remains high among both ART-naive and ART-experienced patients in South Africa. This emphasizes the importance of regular measurement of CD4 cell count as an essential component of HIV care. In addition, providing innovative adherence support and interventions to retain ART patients in effective care is a crucial priority for those on ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08521-4","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T01:02:07Z","timestamp":1692666127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Prevalence and trends of advanced HIV disease among antiretroviral therapy-na\u00efve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Marcel K.","family":"Kitenge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Fatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Eshun-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omololu","family":"Aluko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nyasulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"8521_CR1","unstructured":"HIV\/AIDS JUNPo. Confronting inequalities: lessons for pandemic responses from 40 years of AIDS. Report No: UNAIDS\/JC3020E Global AIDS update Geneva. Joint United Nations Programme on HIV\/AIDS (UNAIDS; 2021."},{"issue":"suppl2","key":"8521_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cid\/cix1140","volume":"66","author":"M Osler","year":"2018","unstructured":"Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G, et al. The Continuing Burden of Advanced HIV Disease over 10 years of increasing antiretroviral Therapy Coverage in South Africa. Clin Infect Dis. 2018;66(suppl2):118\u2013s25.","journal-title":"Clin Infect Dis"},{"issue":"suppl2","key":"8521_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciy045","volume":"66","author":"S Carmona","year":"2018","unstructured":"Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox MP, et al. Persistent high Burden of Advanced HIV Disease among Patients seeking care in South Africa\u2019s National HIV Program: Data from a Nationwide Laboratory Cohort. Clin Infect Dis. 2018;66(suppl2):111\u2013s7.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8521_CR4","doi-asserted-by":"crossref","first-page":"e25546","DOI":"10.1002\/jia2.25546","volume":"23","author":"E Zaniewski","year":"2020","unstructured":"Zaniewski E, Dao Ostinelli CH, Chammartin F, Maxwell N, Davies MA, Euvrard J, et al. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa. J Int AIDS Soc. 2020;23(7):e25546.","journal-title":"J Int AIDS Soc"},{"key":"8521_CR5","unstructured":"Organization WH. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017."},{"key":"8521_CR6","doi-asserted-by":"crossref","first-page":"100991","DOI":"10.1016\/j.eclinm.2021.100991","volume":"38","author":"MS Jamil","year":"2021","unstructured":"Jamil MS, Eshun-Wilson I, Witzel TC, Siegfried N, Figueroa C, Chitembo L, et al. Examining the effects of HIV self-testing compared to standard HIV testing services in the general population: a systematic review and meta-analysis. EClinicalMedicine. 2021;38:100991.","journal-title":"EClinicalMedicine"},{"key":"8521_CR7","unstructured":"UNAIDS. Lessons for pandemic responses from 40 years of AIDS. 2021."},{"issue":"1","key":"8521_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12879-019-3826-5","volume":"19","author":"NA Benzekri","year":"2019","unstructured":"Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, et al. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa. BMC Infect Dis. 2019;19(1):261.","journal-title":"BMC Infect Dis"},{"issue":"9739","key":"8521_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(10)60666-6","volume":"376","author":"M May","year":"2010","unstructured":"May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-saharan Africa: a collaborative analysis of scale-up programmes. The Lancet. 2010;376(9739):449\u201357.","journal-title":"The Lancet"},{"issue":"7","key":"8521_CR10","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1016\/S2352-3018(20)30101-6","volume":"7","author":"Z Ndlovu","year":"2020","unstructured":"Ndlovu Z, Burton R, Stewart R, Bygrave H, Roberts T, Fajardo E, et al. Framework for the implementation of advanced HIV disease diagnostics in sub-saharan Africa: programmatic perspectives. The Lancet HIV. 2020;7(7):e514\u2013e20.","journal-title":"The Lancet HIV"},{"issue":"21","key":"8521_CR11","first-page":"2","volume":"66","author":"AFSR Auld","year":"2017","unstructured":"Auld AFSR, Oboho I, Ross C, Bateganya M, Pelletier V. Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy. Morb Mortal Wkly Rep. 2017;66(21):2\u20137.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5","key":"8521_CR12","doi-asserted-by":"crossref","first-page":"e1003651","DOI":"10.1371\/journal.pmed.1003651","volume":"18","author":"P Ehrenkranz","year":"2021","unstructured":"Ehrenkranz P, Rosen S, Boulle A, Eaton JW, Ford N, Fox MP, et al. The revolving door of HIV care: revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals. PLoS Med. 2021;18(5):e1003651.","journal-title":"PLoS Med"},{"issue":"50","key":"8521_CR13","doi-asserted-by":"crossref","first-page":"e2269","DOI":"10.1097\/MD.0000000000002269","volume":"94","author":"G Meintjes","year":"2015","unstructured":"Meintjes G, Kerkhoff AD, Burton R, Schutz C, Boulle A, Van Wyk G, et al. HIV-Related Medical admissions to a south african District Hospital remain frequent despite effective antiretroviral therapy Scale-Up. Med (Baltim). 2015;94(50):e2269.","journal-title":"Med (Baltim)"},{"issue":"6","key":"8521_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix915","volume":"66","author":"CC IeDea, Collaborations","year":"2018","unstructured":"IeDea, Collaborations CC. Global Trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of Treatment Programs. Clin Infect Dis. 2018;66(6):893\u2013903.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8521_CR15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/cid\/cit421","volume":"57","author":"CR Lesko","year":"2013","unstructured":"Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992\u20132011. Clin Infect Dis. 2013;57(7):1027\u201337.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8521_CR16","first-page":"1120","volume":"60","author":"MJ Siedner","year":"2015","unstructured":"Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-saharan Africa, 2002\u20132013: a meta-analysis. Clin Infect Dis. 2015;60(7):1120\u20137.","journal-title":"Clin Infect Dis"},{"key":"8521_CR17","unstructured":"Organization WH. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: December 2011. World Health Organization; 2011."},{"key":"8521_CR18","unstructured":"Organization WH. The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: policy guidance. World Health Organization; 2015. p. 9241509635. Report No."},{"key":"8521_CR19","unstructured":"Organization WH. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: recommendations for a public health approach. 2006."},{"key":"8521_CR20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"8521_CR21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"8521_CR22","volume-title":"Stata Statistical Software","author":"S Press","year":"2016","unstructured":"Press S. Stata Statistical Software. College Station: Stata Corporation; 2016."},{"issue":"1","key":"8521_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-3258-72-39","volume":"72","author":"VN Nyaga","year":"2014","unstructured":"Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health. 2014;72(1):1\u201310.","journal-title":"Archives of Public Health"},{"issue":"2","key":"8521_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105\u201314.","journal-title":"Contemp Clin Trials"},{"key":"8521_CR25","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis: John Wiley & Sons; 2021.","DOI":"10.1002\/9781119558378"},{"issue":"7119","key":"8521_CR26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.315.7119.1371","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD. Meta-analysis: potentials and promise. BMJ. 1997;315(7119):1371\u20134.","journal-title":"BMJ"},{"key":"8521_CR27","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088 \u2013 101.","DOI":"10.2307\/2533446"},{"issue":"12","key":"8521_CR28","doi-asserted-by":"crossref","first-page":"e15664","DOI":"10.1371\/journal.pone.0015664","volume":"5","author":"VB Patel","year":"2010","unstructured":"Patel VB, Singh R, Connolly C, Kasprowicz V, Zumla A, Ndungu T, et al. Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS ONE. 2010;5(12):e15664.","journal-title":"PLoS ONE"},{"key":"8521_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-9378-6-22","volume":"6","author":"M Maskew","year":"2011","unstructured":"Maskew M, Macphail AP, Whitby D, Egger M, Wallis CL, Fox MP. Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa. Infect Agent Cancer. 2011;6:22.","journal-title":"Infect Agent Cancer"},{"key":"8521_CR30","doi-asserted-by":"crossref","unstructured":"Dramowski A, Coovadia A, Meyers T, Goga A. Identifying missed opportunities for early intervention among HIV-infected paediatric admissions at Chris Hani Baragwanath hospital, Soweto, South Africa. 2011. p. 16\u201323.","DOI":"10.4102\/sajhivmed.v12i4.167"},{"issue":"8","key":"8521_CR31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thx.2011.160168","volume":"66","author":"T Oni","year":"2011","unstructured":"Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax. 2011;66(8):669\u201373.","journal-title":"Thorax"},{"issue":"1","key":"8521_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201101-0056OC","volume":"184","author":"G Theron","year":"2011","unstructured":"Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al. Evaluation of the Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011;184(1):132\u201340.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"8521_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1468-1293.2011.00947.x","volume":"13","author":"K Kranzer","year":"2012","unstructured":"Kranzer K, Govindasamy D, van Schaik N, Thebus E, Davies N, Zimmermann M, et al. Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy. HIV Med. 2012;13(2):132\u20137.","journal-title":"HIV Med"},{"issue":"11","key":"8521_CR34","doi-asserted-by":"crossref","first-page":"e40623","DOI":"10.1371\/journal.pone.0040623","volume":"7","author":"LJ Haddow","year":"2012","unstructured":"Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS ONE. 2012;7(11):e40623.","journal-title":"PLoS ONE"},{"issue":"7","key":"8521_CR35","doi-asserted-by":"crossref","first-page":"e39966","DOI":"10.1371\/journal.pone.0039966","volume":"7","author":"JG Peter","year":"2012","unstructured":"Peter JG, Theron G, Muchinga TE, Govender U, Dheda K. The diagnostic accuracy of urine-based Xpert MTB\/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS ONE. 2012;7(7):e39966.","journal-title":"PLoS ONE"},{"issue":"1","key":"8521_CR36","doi-asserted-by":"crossref","first-page":"55305","DOI":"10.1371\/journal.pone.0055305","volume":"8","author":"K DrainPaul","year":"2013","unstructured":"DrainPaul K, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS ONE. 2013;8(1):55305.","journal-title":"PLoS ONE"},{"issue":"10","key":"8521_CR37","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/cid\/ciu096","volume":"58","author":"S Manicklal","year":"2014","unstructured":"Manicklal S, van Niekerk AM, Kroon SM, Hutto C, Novak Z, Pati SK, et al. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa. Clin Infect Dis. 2014;58(10):1467\u201372.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8521_CR38","doi-asserted-by":"crossref","first-page":"e0133452","DOI":"10.1371\/journal.pone.0133452","volume":"10","author":"TM Rossouw","year":"2015","unstructured":"Rossouw TM, Feucht UD, Melikian G, van Dyk G, Thomas W, du Plessis NM, et al. Factors Associated with the development of Drug Resistance mutations in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy in South Africa. PLoS ONE. 2015;10(7):e0133452.","journal-title":"PLoS ONE"},{"issue":"1","key":"8521_CR39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/09540121.2015.1066748","volume":"28","author":"UD Feucht","year":"2016","unstructured":"Feucht UD, Meyer A, Thomas WN, Forsyth BW, Kruger M. Early diagnosis is critical to ensure good outcomes in HIV-infected children: outlining barriers to care. AIDS Care. 2016;28(1):32\u201342.","journal-title":"AIDS Care"},{"issue":"11","key":"8521_CR40","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/jac\/dkx252","volume":"72","author":"GM Hunt","year":"2017","unstructured":"Hunt GM, Dokubo EK, Takuva S, de Oliveira T, Ledwaba J, Dube N, et al. Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa. J Antimicrob Chemother. 2017;72(11):3141\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"8521_CR41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s10461-016-1442-6","volume":"21","author":"R Cholera","year":"2017","unstructured":"Cholera R, Pence BW, Gaynes BN, Bassett J, Qangule N, Pettifor A, et al. Depression and Engagement in Care among newly diagnosed HIV-Infected adults in Johannesburg, South Africa. AIDS Behav. 2017;21(6):1632\u201340.","journal-title":"AIDS Behav"},{"key":"8521_CR42","doi-asserted-by":"crossref","unstructured":"Mnyani CN, Buchmann EJ, Chersich MF, Frank KA, McIntyre JA. Trends in maternal deaths in HIV-infected women, on a background of changing HIV management guidelines in South Africa: 1997 to 2015. J Int AIDS Soc. 2017;20(3).","DOI":"10.1002\/jia2.25022"},{"issue":"12","key":"8521_CR43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.7196\/SAMJ.2017.v107i12.12358","volume":"107","author":"HN Fomundam","year":"2017","unstructured":"Fomundam HN, Tesfay AR, Mushipe SA, Mosina MB, Boshielo CT, Nyambi HT, et al. Prevalence and predictors of late presentation for HIV care in South Africa. S Afr Med J. 2017;107(12):1058\u201364.","journal-title":"S Afr Med J"},{"key":"8521_CR44","doi-asserted-by":"crossref","unstructured":"Venter DF, Chersich W, Majam MF, Akpomiemie M, Arulappan G, Moorhouse N et al. M,. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values? International Journal of S T D & AIDS. 2018;29(11):1048-56.","DOI":"10.1177\/0956462418771768"},{"issue":"2","key":"8521_CR45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10461-018-2222-2","volume":"23","author":"A Larsen","year":"2019","unstructured":"Larsen A, Cheyip M, Tesfay A, Vranken P, Fomundam H, Wutoh A, et al. Timing and predictors of initiation on antiretroviral therapy among newly-diagnosed HIV-Infected persons in South Africa. AIDS Behav. 2019;23(2):375\u201385.","journal-title":"AIDS Behav"},{"issue":"8","key":"8521_CR46","doi-asserted-by":"crossref","first-page":"e14664","DOI":"10.1097\/MD.0000000000014664","volume":"98","author":"OO Sogbanmu","year":"2019","unstructured":"Sogbanmu OO, Goon DT, Obi LC, Iweriebor BC, Nwodo UN, Ajayi AI, et al. Socio-demographic and clinical determinants of late presentation among patients newly diagnosed with HIV in the Eastern Cape, South Africa. Med (Baltim). 2019;98(8):e14664.","journal-title":"Med (Baltim)"},{"issue":"5","key":"8521_CR47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/myc.13071","volume":"63","author":"E van Schalkwyk","year":"2020","unstructured":"van Schalkwyk E, Mhlanga M, Maphanga TG, Mpembe RS, Shillubane A, Iyaloo S, et al. Screening for invasive fungal disease using non-culture-based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa. Mycoses. 2020;63(5):478\u201387.","journal-title":"Mycoses"},{"issue":"4","key":"8521_CR48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/aid.2019.0206","volume":"36","author":"J Dorward","year":"2020","unstructured":"Dorward J, Drain PK, Osman F, Sookrajh Y, Pillay M, Moodley P, et al. Short communication: early antiretroviral therapy is Associated with Better viral suppression and less HIV Drug Resistance after implementation of Universal Treatment in South Africa. AIDS Res Hum Retroviruses. 2020;36(4):297\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"8521_CR49","doi-asserted-by":"crossref","first-page":"e2031190","DOI":"10.1001\/jamanetworkopen.2020.31190","volume":"4","author":"TM Nir","year":"2021","unstructured":"Nir TM, Fouche JP, Ananworanich J, Ances BM, Boban J, Brew BJ, et al. Association of Immunosuppression and viral load with subcortical brain volume in an International Sample of People living with HIV. JAMA Netw Open. 2021;4(1):e2031190.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8521_CR50","doi-asserted-by":"crossref","first-page":"e25870","DOI":"10.1002\/jia2.25870","volume":"25","author":"P Nyakato","year":"2022","unstructured":"Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, Sipambo N, et al. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15\u201319 years initiating antiretroviral therapy in South Africa: a retrospective cohort study. J Int AIDS Soc. 2022;25(1):e25870.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"8521_CR51","doi-asserted-by":"crossref","first-page":"e0265488","DOI":"10.1371\/journal.pone.0265488","volume":"17","author":"N Conan","year":"2022","unstructured":"Conan N, Simons E, Chihana ML, Ohler L, FordKamara E, Mbatha M, et al. Increase in HIV viral suppression in KwaZulu-Natal, South Africa: community-based cross sectional surveys 2018 and 2013. What remains to be done? PLoS ONE. 2022;17(3):e0265488.","journal-title":"PLoS ONE"},{"issue":"1","key":"8521_CR52","doi-asserted-by":"crossref","first-page":"1679472","DOI":"10.1080\/16549716.2019.1679472","volume":"12","author":"ML Chihana","year":"2019","unstructured":"Chihana ML, Huerga H, Van Cutsem G, Ellman T, Goemaere E, Wanjala S, et al. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), ndhiwa (Kenya) and Chiradzulu (Malawi). Glob Health Action. 2019;12(1):1679472.","journal-title":"Glob Health Action"},{"issue":"9","key":"8521_CR53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2471\/BLT.09.068981","volume":"88","author":"BA Larson","year":"2010","unstructured":"Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Lost opportunities to complete CD4 + lymphocyte testing among patients who tested positive for HIV in South Africa. World Health Organization Bulletin. 2010;88(9):675\u201380.","journal-title":"World Health Organization Bulletin"},{"issue":"9","key":"8521_CR54","doi-asserted-by":"crossref","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","volume":"11","author":"A Boulle","year":"2014","unstructured":"Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS Med. 2014;11(9):e1001718.","journal-title":"PLoS Med"},{"issue":"4","key":"8521_CR55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/tmi.12446","volume":"20","author":"M Kamkuemah","year":"2015","unstructured":"Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a primary Healthcare setting in South Africa. Trop Med Int Health. 2015;20(4):518\u201326.","journal-title":"Trop Med Int Health"},{"issue":"5","key":"8521_CR56","doi-asserted-by":"crossref","first-page":"e0217742","DOI":"10.1371\/journal.pone.0217742","volume":"14","author":"T Kufa","year":"2019","unstructured":"Kufa T, Shubber Z, MacLeod W, Takuva S, Carmona S, Bor J, et al. CD4 count recovery and associated factors among individuals enrolled in the south african antiretroviral therapy programme: an analysis of national laboratory based data. PLoS ONE. 2019;14(5):e0217742.","journal-title":"PLoS ONE"},{"issue":"12","key":"8521_CR57","doi-asserted-by":"crossref","first-page":"e0000336","DOI":"10.1371\/journal.pgph.0000336","volume":"2","author":"A Shigayeva","year":"2022","unstructured":"Shigayeva A, Gcwensa N, Ndlovu CD, Ntumase N, Sabela S, Ohler L, et al. Retention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South Africa. PLOS Glob Public Health. 2022;2(12):e0000336.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"8521_CR58","doi-asserted-by":"crossref","first-page":"e0227572","DOI":"10.1371\/journal.pone.0227572","volume":"15","author":"RR Lilian","year":"2020","unstructured":"Lilian RR, Rees K, McIntyre JA, Struthers HE, Peters RPH. Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: analysis of routine data. PLoS ONE. 2020;15(1):e0227572.","journal-title":"PLoS ONE"},{"issue":"3","key":"8521_CR59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAD.0000000000003442","volume":"37","author":"GE Patten","year":"2023","unstructured":"Patten GE, Euvrard J, Anderegg N, Boulle A, von der Arendse KD, et al. Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model. AIDS. 2023;37(3):513\u201322.","journal-title":"AIDS"},{"issue":"10","key":"8521_CR60","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1016\/S2214-109X(20)30279-5","volume":"8","author":"AD Haas","year":"2020","unstructured":"Haas AD, van den Ruffieux Y, Lund C, Boulle A, Euvrard J, et al. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. Lancet Glob Health. 2020;8(10):e1326\u2013e34.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"8521_CR61","first-page":"505","volume":"110","author":"DK Glencross","year":"2020","unstructured":"Glencross DK, Cassim N, Coetzee LM. Documented higher burden of advanced and very advanced HIV disease among patients, especially men, accessing healthcare in a rapidly growing economic and industrial hub in South Africa: a call to action. S Afr Med J. 2020;110(6):505\u201313.","journal-title":"S Afr Med J"},{"issue":"1","key":"8521_CR62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10461-022-03772-9","volume":"27","author":"T Cassidy","year":"2023","unstructured":"Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Duran LT, de Azevedo V, et al. Attrition from Care among Men initiating ART in male-only clinics compared with men in General Primary Healthcare Clinics in Khayelitsha, South Africa: a matched propensity score analysis. AIDS Behav. 2023;27(1):358\u201369.","journal-title":"AIDS Behav"},{"issue":"4","key":"8521_CR63","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","volume":"56","author":"A Van Rie","year":"2011","unstructured":"Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011;56(4):349\u201355.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"8521_CR64","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","volume":"8","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study. PLoS Med. 2011;8(7):e1001067.","journal-title":"PLoS Med"},{"issue":"4","key":"8521_CR65","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/QAD.0b013e32835c12f9","volume":"27","author":"K Clouse","year":"2013","unstructured":"Clouse K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, et al. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. Aids. 2013;27(4):645\u201350.","journal-title":"Aids"},{"issue":"9","key":"8521_CR66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5588\/ijtld.12.0891","volume":"17","author":"KN Otwombe","year":"2013","unstructured":"Otwombe KN, Variava E, Holmes CB, Chaisson RE, Martinson N. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa. Int J Tuberc Lung Dis. 2013;17(9):1199\u2013205.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8521_CR67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.11604\/pamj.2014.19.114.3600","volume":"19","author":"Z Ndlovu","year":"2014","unstructured":"Ndlovu Z, Chirwa T, Takuva S. Incidence and predictors of recovery from anaemia within an HIV-infected south african cohort, 2004\u20132010. Pan Afr Med J. 2014;19:114.","journal-title":"Pan Afr Med J"},{"issue":"8","key":"8521_CR68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/sextrans-2013-051446","volume":"90","author":"MN Lurie","year":"2014","unstructured":"Lurie MN, Kirwa K, Daniels J, Berteler M, Kalichman SC, Mathews C. High burden of STIs among HIV-infected adults prior to initiation of ART in South Africa: a retrospective cohort study. Sex Transm Infect. 2014;90(8):615\u20139.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"8521_CR69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12913-018-2942-z","volume":"18","author":"OV Adeniyi","year":"2018","unstructured":"Adeniyi OV, Ajayi AI, Moyaki MG, Goon DT, Avramovic G, Lambert J. High rate of unplanned pregnancy in the context of integrated family planning and HIV care services in South Africa. BMC Health Serv Res. 2018;18(1):140.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"8521_CR70","doi-asserted-by":"crossref","first-page":"e0195127","DOI":"10.1371\/journal.pone.0195127","volume":"13","author":"P Bock","year":"2018","unstructured":"Bock P, Fatti G, Ford N, Jennings K, Kruger J, Gunst C, et al. Attrition when providing antiretroviral treatment at CD4 counts > 500cells\/\u00b5L at three government clinics included in the HPTN 071 (PopART) trial in South Africa. PLoS ONE. 2018;13(4):e0195127.","journal-title":"PLoS ONE"},{"issue":"9","key":"8521_CR71","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciy309","volume":"67","author":"MS Rane","year":"2018","unstructured":"Rane MS, Hong T, Govere S, Thulare H, Moosa MY, Celum C, et al. Depression and anxiety as risk factors for delayed care-seeking behavior in human immunodeficiency virus-infected individuals in South Africa. Clin Infect Dis. 2018;67(9):1411\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8521_CR72","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s10461-018-2364-2","volume":"23","author":"JF Magidson","year":"2019","unstructured":"Magidson JF, Fatch R, Orrell C, Amanyire G, Haberer JE, Hahn JA. Biomarker-measured unhealthy alcohol use in relation to CD4 count among individuals starting ART in Sub-Saharan Africa. AIDS Behav. 2019;23(6):1656\u201367.","journal-title":"AIDS Behav"},{"issue":"3","key":"8521_CR73","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/QAI.0b013e31824445f0","volume":"59","author":"MD Nglazi","year":"2012","unstructured":"Nglazi MD, van Schaik N, Kranzer K, Lawn SD, Wood R, Bekker LG. An incentivized HIV counseling and testing program targeting hard-to-reach unemployed men in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2012;59(3):e28\u201334.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"8521_CR74","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/QAI.0000000000000060","volume":"65","author":"K Naidoo","year":"2014","unstructured":"Naidoo K, Karim QA, Bhushan A, Yende-Zuma N, McHunu PK, Frohlich J, et al. High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr. 2014;65(4):438\u201346.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"8521_CR75","doi-asserted-by":"crossref","first-page":"e0121843","DOI":"10.1371\/journal.pone.0121843","volume":"10","author":"PH Maduna","year":"2015","unstructured":"Maduna PH, Dolan M, Kondlo L, Mabuza H, Dlamini JN, Polis M, et al. Morbidity and mortality according to latest CD4 + cell count among HIV positive individuals in South Africa who enrolled in project Phidisa. PLoS ONE. 2015;10(4):e0121843.","journal-title":"PLoS ONE"},{"issue":"Suppl 6","key":"8521_CR76","doi-asserted-by":"crossref","first-page":"e25802","DOI":"10.1002\/jia2.25802","volume":"24","author":"L Lewis","year":"2021","unstructured":"Lewis L, Sookrajh Y, Gate K, Khubone T, Maraj M, Mkhize S, et al. Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa. J Int AIDS Soc. 2021;24(Suppl 6):e25802.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08521-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08521-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08521-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T04:04:23Z","timestamp":1700280263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08521-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8521"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08521-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"549"}}